Dr. Geoffrey Liu discussed findings from the phase 2 TRUST-II clinical trial evaluating Ibtrozi (taletrectinib) among ...

University of Colorado Cancer Center member D. Ross Camidge, MD, PhD, has spent his career fighting lung cancer. In 2022, ...

She's one of 108 participants within her company that is partnering with the V Foundation for Cancer Research.

Two regional cancer patients have become trailblazers for a cutting-edge procedure promising faster recovery, less pain and ...

In patients with advanced cancer in South Korea, there was an increase in broad-spectrum antibiotic use from 3 months to 2 ...

Urgently referred patients are having to wait more than 28 days to receive a cancer diagnosis, exceeding NHS England’s target ...

In fact, a study published in the Journal of Royal Society of Medicine revealed that if lung cancer in non-smokers was ...